SMTL ID : 2o5d.1 (1 other biounit)

Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: Convergence of structure-based drug design and X-ray crystallographic study

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x VR1: (2S)-2-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)-2-(4-FLUOROPHENYL)-N-[(4-NITROPHENYL)SULFONYL]ACETAMIDE(Non-covalent)

VR1.1: 15 residues within 4Å: Chain A: L.425, R.428, M.429, L.480, H.481, S.482, Y.483, I.488, V.491, A.492, L.503, R.507, W.534, V.536, K.539 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:L.425, A:L.425, A:I.488, A:V.491, A:A.492, A:L.503, A:L.503, A:W.534, A:W.534, A:K.539 Hydrogen bonds: A:S.482, A:Y.483, A:R.507, A:R.507 Water bridges: A:R.428 pi-Stacking: A:Y.483

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yan, S. et al., Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: Convergence of structure-based drug design and X-ray crystallographic study. Bioorg.Med.Chem.Lett. (2007)

Release Date

2007-02-20

Peptides

HCV: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

HCV

Related Entries With Identical Sequence